Expertise in
1
conditions

Teresa Cedena

Madrid, MD, ES 
Expertise in
1
conditions
Madrid, MD, ES 

Overview

Teresa Cedena practices practicing medicine in Madrid, Spain.

Ms. Cedena is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Multiple Myeloma, Myelodysplastic Syndrome (MDS), Leukemia, and Acute Myeloid Leukemia (AML).

She is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Madrid, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Compound Eltanexor (KPT-8602) in Patients With Newly Diagnosed and Relapsed/Refractory Cancer Indications
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drug: KPT-8602
Study Phase: Phase 1/Phase 2

11 Total Publications

Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, nonrandomized, multicenter GEM-SELIBORDARA study.
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, nonrandomized, multicenter GEM-SELIBORDARA study.
Journal: Haematologica
Published: September 20, 2023

Frequently Asked Questions about Teresa Cedena

Is Teresa Cedena a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Teresa Cedena is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Teresa Cedena participate in research or clinical trials?

Yes. Teresa Cedena has published 11 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Teresa Cedena's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cedena's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile